The REVEAL score estimates prognosis for patients with pulmonary arterial hypertension, combining clinical, functional, and hemodynamic data into a risk score used to guide treatment intensity.
Check the adverse indicators present. More indicators reflect higher risk. This is a simplified educational indicator set — the validated REVEAL score applies a weighted multivariable calculation and should be used for clinical risk stratification.
Primarily pulmonary hypertension specialists managing treatment decisions for a condition complex enough to need dedicated risk stratification beyond general respiratory scores.
No — this is a simplified educational indicator set. The validated REVEAL score uses a weighted multivariable model incorporating WHO functional class, hemodynamics, functional tests, and labs.
Prognosis in pulmonary arterial hypertension — it's used to guide how intensively to treat and how closely to follow a patient.
PAH prognosis reflects multiple domains at once; combining functional, hemodynamic, and laboratory markers predicts outcomes better than any single value.